Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 25 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 7378273

    Expression vectors

    Gala Design, Inc. · Granted May 27, 2008 · Expires May 22, 2028

    granted

  2. US 2008107607

    TARGETING VECTOR-PHOSPHOLIPID CONJUGATES

    BRACCO INT BV [NL] · Granted May 8, 2008 · Expires May 3, 2028

    granted

  3. US 7365171

    Chemokine-like factors (CKLFs) with chemotactic and hematopoietic stimulating activities

    Beijing Medical University United Biological Engineering Company · Granted Apr 29, 2008 · Expires Apr 24, 2028

    granted

  4. US 7351411

    Methods of treating anemia by inhibition of vascular endothelial growth factor (VEGF)

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 1, 2008 · Expires Mar 27, 2028

    granted

  5. US 7339037

    Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins

    The United States of America, as represented by the Department of Health and Human Services · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted

  6. US 7319134

    Regulation of transcription factor, NF-IL6/LAP

    The Regents of the University of California · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted

  7. US 7314618

    Antibodies to fibroblast growth factor (FGF23)

    Ludwig-Maximilians-Universitat Munchen · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

  8. US 7314631

    Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV)

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

  9. US 7288671

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

  10. US 7285542

    Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Oct 23, 2007 · Expires Oct 18, 2027

    granted

  11. US 7264947

    Activity dependent neurotrophic factor III (ADNF III)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 4, 2007 · Expires Aug 30, 2027

    granted

  12. US 7252989

    Adenovirus supervector system

    The Board of Regents of the University of Texas System · Granted Aug 7, 2007 · Expires Aug 2, 2027

    granted

  13. US 7247707

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Jul 24, 2007 · Expires Jul 19, 2027

    granted

  14. US 7241860

    Transcription factor polypeptide that regulates Chondromodulin-I expression

    Takeda Pharmaceutical Company Limited · Granted Jul 10, 2007 · Expires Jul 5, 2027

    granted

  15. US 7223563

    Fibroblast growth factor (FGF23) nucleic acids

    Ludwig-Maximilians-Universitat Munchen · Granted May 29, 2007 · Expires May 24, 2027

    granted

  16. US 7211402

    Transcription factor coactivator protein, p/CIP

    The Regents of the University of California · Granted May 1, 2007 · Expires Apr 26, 2027

    granted

  17. US 7211432

    Recombinant vector expressing multiple costimulatory molecules and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 1, 2007 · Expires Apr 26, 2027

    granted

  18. US 7208313

    Combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Apr 24, 2007 · Expires Apr 19, 2027

    granted

  19. US 7199223

    Polymer-factor VIII moiety conjugates

    Nektar Therapeutics AL, Corporation · Granted Apr 3, 2007 · Expires Mar 29, 2027

    granted

  20. US 7192593

    Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Mar 20, 2007 · Expires Mar 15, 2027

    granted

  21. US 7192914

    Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor

    The Regents of the University of California · Granted Mar 20, 2007 · Expires Mar 15, 2027

    granted

  22. US 7193075

    Sequences upstream of the CARP gene, vectors containing them and uses thereof

    The Regents of the University of California · Granted Mar 20, 2007 · Expires Mar 15, 2027

    granted

  23. US 7193053

    Hypoxia-inducible factor 1alpha variants and methods of use

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Mar 20, 2007 · Expires Mar 15, 2027

    granted

  24. US 7179621

    Pigment epithelium-derived factor: sequence of the PEDF gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 20, 2007 · Expires Feb 15, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.